Short Description

Acute myeloid leukemia (AML) is a neoplastic disease of the hematopoietic stem cell defined by impaired differentiation capacity, clonal expansion and accumulation of immature cells with suppression of polyclonal residual hematopoiesis. The resulting peripheral cytopenias accounts for the most frequent clinical symptoms at diagnosis (fatigue, dyspnea,fever and infections, hemorrhage). The sequencing of genes related to pathophysiology of AML helps in making diagnosis, and also for prognostication and therapeutic decision making.

PreTest Information

Duly filled NGS Test Requisition Form (Form 40) is mandatory.

Detail Description

ONCOMINE ACUTE MYELOID LEUKAEMIA (AML) PANEL Test

Acute myeloid leukemia (AML) is a type of cancer that affects the blood and bone marrow. This type of cancer is characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells. AML can cause symptoms such as fatigue, weakness, fever, and infections.

At DNA Labs India, we offer the ONCOMINE AML Panel Test, which is a comprehensive genetic test that can help diagnose AML and guide treatment decisions. This test analyzes a patient's DNA to detect genetic mutations that are commonly found in AML. The ONCOMINE AML Panel Test is a valuable tool for doctors in developing a personalized treatment plan for their patients.

Symptoms of AML

AML can cause a range of symptoms, including:

• Fatigue and weakness
• Fever and chills
• Shortness of breath
• Bleeding and bruising easily
• Recurrent infections
• Unexplained weight loss

Diagnosing AML

To diagnose AML, doctors typically perform a physical exam and blood tests. If AML is suspected, a bone marrow biopsy may be performed to confirm the diagnosis and determine the subtype of AML. The ONCOMINE AML Panel Test can provide additional information about the genetic mutations present in the cancer cells, which can help doctors develop a personalized treatment plan.

The Cost of the ONCOMINE AML Panel Test

The cost of the ONCOMINE AML Panel Test at DNA Labs India is INR 40,950. This cost includes the genetic testing and interpretation, as well as a detailed report that summarizes the results of the test.

Conclusion

The ONCOMINE AML Panel Test is a valuable tool for diagnosing AML and guiding treatment decisions. This test can help doctors develop a personalized treatment plan for their patients, which can improve outcomes and quality of life. If you are experiencing symptoms of AML or have been diagnosed with AML, talk to your doctor about the ONCOMINE AML Panel Test and how it can benefit you.

Acute myeloid leukemia (AML) is a neoplastic disease of the hematopoietic stem cell defined by impaired differentiation capacity, clonal expansion and accumulation of immature cells with suppression of polyclonal residual hematopoiesis. The resulting peripheral cytopenias accounts for the most frequent clinical symptoms at diagnosis (fatigue, dyspnea,fever and infections, hemorrhage). The sequencing of genes related to pathophysiology of AML helps in making diagnosis, and also for prognostication and therapeutic decision making.